Study to Evaluate Use of Albuterol Multidose Dry Powder Inhaler With an eModule in Participants With Asthma

Study Title

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

Teva Identifier

ABS-AS-30064

ClinicalTrials.gov Identifier

NCT02969408

Study Status

Completed

Trial Condition(s)

Asthma

Interventions

Drug: Albuterol Sulfate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years and older

Trial Duration

February 13, 2017 - February 2, 2018

Phase

Phase 3

Study Type

Interventional